United Therapeutics (UTHR) Leases (2022)
United Therapeutics (UTHR) reported Leases of $12.2 million for Q3 2022.
United Therapeutics (UTHR) Leases (2022) Analysis & Trends
United Therapeutics (UTHR) has 1 years of Leases data on file, last reported at $12.2 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 335.00 Mn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 282.00 Mn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | 1.06 Mn |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 253.00 Mn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 447.10 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 84.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12.20 Mn |